Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where ALPS declined for three days, in 58 of 75 cases, the price declined further within the following month. The odds of a continued downward trend are 77%.
The Momentum Indicator moved below the 0 level on October 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ALPS as a result. In 19 of 65 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 29%.
The Moving Average Convergence Divergence Histogram (MACD) for ALPS turned negative on October 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 10 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 20%.
ALPS moved below its 50-day moving average on October 07, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for ALPS crossed bearishly below the 50-day moving average on October 14, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 2 of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 17%.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +7.43% 3-day Advance, the price is estimated to grow further. Considering data from situations where ALPS advanced for three days, in 35 of 70 cases, the price rose further within the following month. The odds of a continued upward trend are 50%.
ALPS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 51 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (2.973). P/E Ratio (0.000) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (13.699) is also within normal values, averaging (438.009).
The Tickeron Price Growth Rating for this company is 89 (best 1 - 100 worst), indicating slightly worse than average price growth. ALPS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALPS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
QURE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 27 of 33 cases where QURE's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 82%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where QURE's RSI Indicator exited the oversold zone, 26 of 35 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 74%.
The Momentum Indicator moved above the 0 level on October 22, 2026. You may want to consider a long position or call options on QURE as a result. In 67 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 81%.
The Moving Average Convergence Divergence (MACD) for QURE just turned positive on October 16, 2026. Looking at past instances where QURE's MACD turned positive, the stock continued to rise in 33 of 41 cases over the following month. The odds of a continued upward trend are 80%.
Following a +4.29% 3-day Advance, the price is estimated to grow further. Considering data from situations where QURE advanced for three days, in 206 of 267 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
QURE moved below its 50-day moving average on September 23, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for QURE crossed bearishly below the 50-day moving average on September 18, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 17 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where QURE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
The Aroon Indicator for QURE entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 12 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 41 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.947) is normal, around the industry mean (2.973). P/E Ratio (-5.692) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.020) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (142.857) is also within normal values, averaging (438.009).
The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating steady price growth. QURE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. QURE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
QURE | ||
|---|---|---|
OUTLOOK RATING 1..100 | 2 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 41 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 99 | |
PRICE GROWTH RATING 1..100 | 65 | |
P/E GROWTH RATING 1..100 | 12 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| ALPS | QURE | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 64% | 1 day ago 74% |
| Stochastic ODDS (%) | 1 day ago 40% | 1 day ago 90% |
| Momentum ODDS (%) | 1 day ago 29% | 1 day ago 81% |
| MACD ODDS (%) | 1 day ago 20% | 1 day ago 80% |
| TrendWeek ODDS (%) | 1 day ago 43% | 1 day ago 78% |
| TrendMonth ODDS (%) | 1 day ago 48% | 1 day ago 88% |
| Advances ODDS (%) | 14 days ago 50% | 3 days ago 77% |
| Declines ODDS (%) | 8 days ago 77% | 9 days ago 86% |
| BollingerBands ODDS (%) | 1 day ago 53% | 1 day ago 82% |
| Aroon ODDS (%) | N/A | 1 day ago 88% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ALPS’s FA Score shows that 0 FA rating(s) are green while QURE’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ALPS’s TA Score shows that 4 TA indicator(s) are bullish while QURE’s TA Score has 4 bullish TA indicator(s).
ALPS (@Biotechnology) experienced а -5.69% price change this week, while QURE (@Biotechnology) price change was +2.62% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -1.10%. For the same industry, the average monthly price growth was -18.18%, and the average quarterly price growth was -15.20%.
QURE is expected to report earnings on Nov 09, 2026.
Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
A.I.dvisor tells us that ALPS and ACIU have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ALPS and ACIU's prices will move in lockstep.
| Ticker / NAME | Correlation To ALPS | 1D Price Change % | ||
|---|---|---|---|---|
| ALPS | 100% | -0.64% | ||
| ACIU - ALPS | 22% Poorly correlated | +1.21% | ||
| VNDA - ALPS | 22% Poorly correlated | +1.00% | ||
| VERU - ALPS | 21% Poorly correlated | -0.43% | ||
| QURE - ALPS | 20% Poorly correlated | +1.85% | ||
| SLDB - ALPS | 20% Poorly correlated | -3.43% | ||
More | ||||
A.I.dvisor indicates that over the last year, QURE has been loosely correlated with CNTN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if QURE jumps, then CNTN could also see price increases.
| Ticker / NAME | Correlation To QURE | 1D Price Change % | ||
|---|---|---|---|---|
| QURE | 100% | +1.85% | ||
| CNTN - QURE | 49% Loosely correlated | -3.63% | ||
| AXON - QURE | 42% Loosely correlated | +2.98% | ||
| MLTX - QURE | 37% Loosely correlated | +15.87% | ||
| SNGX - QURE | 36% Loosely correlated | +0.30% | ||
| STOK - QURE | 34% Loosely correlated | +0.08% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SPLB | 21.07 | 0.30 | +1.44% |
| State Street SPDR Portfolio Long Term Corporate Bond ETF (SPLB) | |||
| BKSE | 42.32 | 0.21 | +0.51% |
| BNY Mellon US Small Cap Core Equity ETF (BKSE) | |||
| GEMG | 3.52 | N/A | N/A |
| Leverage Shares 2X Long GEMI Daily ETF (GEMG) | |||
| QUSA | 16.65 | -0.51 | -2.97% |
| Vistashares Target 15 Usa Quality Income ETF | |||
| PBW | 24.54 | -1.03 | -4.03% |
| Invesco WilderHill Clean Energy ETF (PBW) | |||